福光股份(688010.SH):公司定製產品主要包含特種光學鏡頭及光電系統
格隆匯8月2日丨福光股份(688010.SH)近期在接待機構投資者調研時表示,公司定製產品主要包含特種光學鏡頭及光電系統,廣泛應用於“神舟系列”、“嫦娥探月”、“天問一號”等國家重大航天任務及高端裝備,公司與中國科學院及各大集團下屬科研院所、企業等直接洽談合作,部分新品開發項目通過競標獲取訂單。新品項目定價方面,定製產品採用審價、協商定價相結合模式,綜合考慮技術複雜程度、實驗等要求對項目的影響,與交易對方協商後最終確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.